| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |